From the Division of Plastic Surgery, New York-Presbyterian Weill Cornell Medical Center, New York, NY.
Ann Plast Surg. 2022 May 1;88(3 Suppl 3):S205-S208. doi: 10.1097/SAP.0000000000003188.
INTRODUCTION: Acellular dermal matrix (ADM) is frequently used during prepectoral tissue expander-based breast reconstruction. However, there has been a paucity of literature describing the experience of prepectoral reconstruction without the accompanying use of ADM. We seek to highlight our institutional experience with immediate prepectoral tissue expander placement without the use of ADM in breast reconstruction. METHODS: A retrospective, single-institution review of patient records was performed to identify all patients who underwent either skin sparing or nipple-sparing mastectomy with immediate tissue expander placement without the use of ADM. Demographics including age, body mass index, comorbidities, history of smoking or steroid use, perioperative radiation or chemotherapy, intraoperative details, and complication profiles during the tissue expander stage were retrospectively collected and analyzed. At the time of tissue expander placement, all mastectomy flaps were evaluated clinically and with indocyanine green laser angiography. Postoperative outcomes were tracked. RESULTS: Between 2017 and 2020, 63 patients (for a total of 108 breasts) underwent either skin sparing (16%) or nipple-sparing mastectomy (84%) with immediate prepectoral tissue expander without ADM placement. Fourteen percent of breasts developed postoperative cellulitis, 19% of breasts developed skin compromise, and 5% required a postoperative revisional procedure that did not result in immediate expander explant. There was a 13% (n = 14 breasts) explant rate occurring at a mean time of 74 days. Of those breasts that developed skin compromise, 45% went on to require eventual explant. Patients in the study were followed for an average of 6.3 months. CONCLUSIONS: Immediate prepectoral breast reconstruction using tissue expanders without ADM offers a viable alternative to established reconstructive paradigms. The major complication rate for prepectoral reconstruction without the use of ADM (17%) was found to be comparable with our historical subpectoral tissue expander reconstruction with ADM use. Tissue expander explant rates were also comparable between the prepectoral without ADM (13%) and the subpectoral with ADM cohorts. These preliminary data suggest that immediate breast reconstruction with tissue expander placement without accompanying ADM is viable alternative in the breast reconstructive algorithm.
简介:脱细胞真皮基质(ADM)在经胸肌前置组织扩张器乳房重建中经常使用。然而,几乎没有文献描述在不使用 ADM 的情况下进行经胸肌前置乳房重建的经验。我们旨在强调我们机构在不使用 ADM 的情况下进行即刻经胸肌前置组织扩张器植入乳房重建的经验。
方法:对患者病历进行回顾性单机构研究,以确定所有接受过保留皮肤或保留乳头的乳房切除术并即刻使用组织扩张器植入而不使用 ADM 的患者。回顾性收集并分析了包括年龄、体重指数、合并症、吸烟或类固醇使用史、围手术期放疗或化疗、手术细节以及组织扩张器阶段的并发症概况在内的人口统计学数据。在放置组织扩张器时,对所有乳房切除术皮瓣进行临床和吲哚菁绿激光血管造影评估。跟踪术后结果。
结果:在 2017 年至 2020 年间,有 63 名患者(共 108 个乳房)接受了保留皮肤(16%)或保留乳头的乳房切除术(84%),并即刻在没有 ADM 放置的情况下进行了经胸肌前置组织扩张器植入。14%的乳房发生术后蜂窝织炎,19%的乳房发生皮肤并发症,5%需要进行术后修正手术,但并未导致即刻扩张器取出。扩张器取出率为 13%(n=14 个乳房),平均时间为 74 天。发生皮肤并发症的乳房中,45%最终需要取出。研究中的患者平均随访 6.3 个月。
结论:使用组织扩张器即刻进行经胸肌前置乳房重建而不使用 ADM 为既定重建模式提供了一种可行的替代方案。不使用 ADM 的经胸肌前置重建的主要并发症发生率(17%)与我们历史上使用 ADM 的胸肌下组织扩张器重建相当。不使用 ADM 的经胸肌前置(13%)和使用 ADM 的胸肌下组织扩张器队列之间的扩张器取出率也相当。这些初步数据表明,在乳房重建算法中,使用组织扩张器即刻放置而不伴随 ADM 是一种可行的替代方案。
Ann Plast Surg. 2022-5-1
Ann Plast Surg. 2020-7
Plast Reconstr Surg Glob Open. 2023-3-13